Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Trial of Ampakine Added to Clozapine, Olanzapine or Risperidone in Patients With Schizophrenia (CX516)

This study has been completed.
Sponsor:
Collaborator:
RespireRx
Information provided by:
North Suffolk Mental Health Association
ClinicalTrials.gov Identifier:
NCT00235352
First received: October 6, 2005
Last updated: February 25, 2009
Last verified: February 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2007
  Primary Completion Date: April 2005 (Final data collection date for primary outcome measure)
Publications: